Fundraising FoxNew Haven Pharmaceuticals
North Haven, US · Delaware corporation · 1 known investors
Find your way into New Haven Pharmaceuticals
Sign up to see every warm intro you have to New Haven Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the New Haven Pharmaceuticals team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
PF
Patrick FourteauExecutive
NM
Nancy MotolaExecutive
HH
Harry H. Penner, Jr.Named on SEC filing
Board
CE
Christopher EcklundBoard director
TS
Theodore StanleyBoard director
WS
William SessaBoard director
DW
Daniel WagnerBoard director
LD
Larry DillahaBoard director
Investors · 1
Connecticut InnovationsreportedNew Haven · $500K – $2M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$12.4M disclosed across 2 rounds · 2014–2016
▶$602.2KraisedAug 2016 · 3 investors · PharmaceuticalsRule 506(b)
▶$602.2KraisedAug 2016 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Harry H. Penner, Jr.Executive Officer, Director
- Christopher EcklundDirector
- Theodore StanleyDirector
- William SessaDirector
- Daniel WagnerDirector
- Larry DillahaDirector
- Patrick FourteauExecutive Officer, Director
- Offering amount
- $1.3M
- Amount sold
- $602.2K
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.8MraisedOct 2014 · 9 investors · PharmaceuticalsRule 506(b)
▶$11.8MraisedOct 2014 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- William SessaDirector
- Larry DillahaDirector
- Harry Penner, Jr.Executive Officer, Director
- Patrick FourteauExecutive Officer, Director
- Daniel WagnerDirector
- Nancy MotolaExecutive Officer
- Offering amount
- $21.8M
- Amount sold
- $11.8M
- First sale
- Oct 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are New Haven Pharmaceuticals's investors?
- New Haven Pharmaceuticals's investors include Connecticut Innovations.
- How much funding has New Haven Pharmaceuticals raised?
- New Haven Pharmaceuticals has disclosed $12.4M raised across 2 rounds.
- Where is New Haven Pharmaceuticals headquartered?
- New Haven Pharmaceuticals is headquartered in North Haven, US.